IT1395143B1 - Composizioni granulari a rilascio controllato di mesalazina e processo per il loro ottenimento. - Google Patents

Composizioni granulari a rilascio controllato di mesalazina e processo per il loro ottenimento.

Info

Publication number
IT1395143B1
IT1395143B1 ITMI2009A001434A ITMI20091434A IT1395143B1 IT 1395143 B1 IT1395143 B1 IT 1395143B1 IT MI2009A001434 A ITMI2009A001434 A IT MI2009A001434A IT MI20091434 A ITMI20091434 A IT MI20091434A IT 1395143 B1 IT1395143 B1 IT 1395143B1
Authority
IT
Italy
Prior art keywords
mesalazine
achievement
controlled release
granular compositions
granular
Prior art date
Application number
ITMI2009A001434A
Other languages
English (en)
Inventor
Carla Labruzzo
Antonio Mannello
Original Assignee
Sofar Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41582217&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1395143(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sofar Spa filed Critical Sofar Spa
Priority to ITMI2009A001434A priority Critical patent/IT1395143B1/it
Priority to PCT/IB2010/053329 priority patent/WO2011015964A1/en
Priority to US13/388,749 priority patent/US8916201B2/en
Priority to ES10752187T priority patent/ES2683098T5/es
Priority to PT107521874T priority patent/PT2461802T/pt
Priority to EP10752187.4A priority patent/EP2461802B2/en
Priority to DK10752187.4T priority patent/DK2461802T4/da
Priority to CA2768425A priority patent/CA2768425C/en
Publication of ITMI20091434A1 publication Critical patent/ITMI20091434A1/it
Publication of IT1395143B1 publication Critical patent/IT1395143B1/it
Application granted granted Critical
Priority to CY181100897T priority patent/CY1120915T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
ITMI2009A001434A 2009-08-06 2009-08-06 Composizioni granulari a rilascio controllato di mesalazina e processo per il loro ottenimento. IT1395143B1 (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI2009A001434A IT1395143B1 (it) 2009-08-06 2009-08-06 Composizioni granulari a rilascio controllato di mesalazina e processo per il loro ottenimento.
PT107521874T PT2461802T (pt) 2009-08-06 2010-07-21 Composições granulares de libertação controlada contendo mesalazina e processo para o seu fabrico
US13/388,749 US8916201B2 (en) 2009-08-06 2010-07-21 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof
ES10752187T ES2683098T5 (es) 2009-08-06 2010-07-21 Composiciones granulares de liberación controlada que contienen mesalazina y procedimiento para la fabricación de las mismas
PCT/IB2010/053329 WO2011015964A1 (en) 2009-08-06 2010-07-21 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof
EP10752187.4A EP2461802B2 (en) 2009-08-06 2010-07-21 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof.
DK10752187.4T DK2461802T4 (da) 2009-08-06 2010-07-21 Granulære sammensætninger med styret frigivelse indeholdende mesalazin og fremgangsmåde til fremstilling deraf
CA2768425A CA2768425C (en) 2009-08-06 2010-07-21 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof
CY181100897T CY1120915T1 (el) 2009-08-06 2018-08-28 Κοκκωδεις συνθεσεις ελεγχομενης αποδεσμευσης που περιλαμβανουν μεσαλαζινη και διεργασια για την παρασκευη τους

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A001434A IT1395143B1 (it) 2009-08-06 2009-08-06 Composizioni granulari a rilascio controllato di mesalazina e processo per il loro ottenimento.

Publications (2)

Publication Number Publication Date
ITMI20091434A1 ITMI20091434A1 (it) 2011-02-07
IT1395143B1 true IT1395143B1 (it) 2012-09-05

Family

ID=41582217

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A001434A IT1395143B1 (it) 2009-08-06 2009-08-06 Composizioni granulari a rilascio controllato di mesalazina e processo per il loro ottenimento.

Country Status (9)

Country Link
US (1) US8916201B2 (it)
EP (1) EP2461802B2 (it)
CA (1) CA2768425C (it)
CY (1) CY1120915T1 (it)
DK (1) DK2461802T4 (it)
ES (1) ES2683098T5 (it)
IT (1) IT1395143B1 (it)
PT (1) PT2461802T (it)
WO (1) WO2011015964A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
EP3131535B1 (en) * 2014-04-17 2020-04-29 Athena Drug Delivery Solutions Pvt Ltd. Process for preparation of mesalamine composition and mesalamine composition thereof
TR201722852A2 (tr) 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Mesalazi̇ni̇n oral farmasöti̇k kompozi̇syonlari

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
JPH072650A (ja) 1993-06-18 1995-01-06 Tanabe Seiyaku Co Ltd 放出部位制御型製剤
US5686106A (en) 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
US5824339A (en) * 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
WO1998022096A1 (en) 1996-11-15 1998-05-28 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US20030180352A1 (en) † 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
IT1318376B1 (it) * 2000-03-07 2003-08-25 Pharmatec Internat S R L Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.
DE10013029A1 (de) † 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US20070059368A1 (en) * 2005-05-31 2007-03-15 Cherukuri S R Modified release formulations of anti-irritability drugs
US9149439B2 (en) * 2005-03-21 2015-10-06 Sandoz Ag Multi-particulate, modified-release composition
US20090017110A1 (en) * 2005-05-31 2009-01-15 Capricorn Pharma Inc. Modified release formulations of anti-irritability drugs

Also Published As

Publication number Publication date
DK2461802T4 (da) 2022-11-07
ITMI20091434A1 (it) 2011-02-07
US20120141592A1 (en) 2012-06-07
EP2461802B2 (en) 2022-08-03
CY1120915T1 (el) 2019-12-11
PT2461802T (pt) 2018-08-08
ES2683098T3 (es) 2018-09-25
CA2768425C (en) 2018-02-27
WO2011015964A1 (en) 2011-02-10
ES2683098T5 (es) 2022-11-18
EP2461802A1 (en) 2012-06-13
CA2768425A1 (en) 2011-02-10
EP2461802B1 (en) 2018-05-30
DK2461802T3 (en) 2018-08-20
US8916201B2 (en) 2014-12-23

Similar Documents

Publication Publication Date Title
SMT201400100B (it) Processo migliorato
BR112012000822A2 (pt) processo
BR112012000421A2 (pt) composições e métodos para intensificar a produção de um produto biológico.
BRPI1010766A2 (pt) processo para rebaudiosídeo d
BR112012012338A2 (pt) processo
BRPI1012574A2 (pt) distribuição de tensão de estria aperfeiçoada
BRPI0909427A2 (pt) resinas carregadas e método para a produção de resinas carregadas
BR112012005321A2 (pt) processo e composição
BRPI1014911A2 (pt) processo para fabricação de resinas carregadas
BR112012014490A2 (pt) processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses
BRPI1014812A2 (pt) Processo para a produção de alacoóis
EP2374802A4 (en) KYNURENIN PRODUCTION INHIBITOR
BR112012005418A2 (pt) processo para a produção de grânulos
BR112013008883A2 (pt) processo para a fabricação de di-hidropteridinonas
BRPI1012134A2 (pt) processo de carbolinação
BRPI1007391A2 (pt) processo para o resfriamento controlado da troposfera
BR112013006230C8 (pt) processo para a preparação de uma n-fenilhidroxilamina substituída
BRPI1007573A2 (pt) processo
BR112012001274A2 (pt) processo para produção de ácidos decancarboxílicos
BR112012024474A2 (pt) processo
BRPI1008117A2 (pt) Processo para a sintese de cleistantina
BR112012003642A2 (pt) processo
BR112012001731A2 (pt) Processo para a preparação de 1-benzil-3-hidroximetil-1h-indazol
BR112012010170A2 (pt) composições de revestimento para desintegração/dissolução rápida
BR112012002069A2 (pt) processo de granulação e granulados assim preparados